Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Autism
PediaMed completes clinical trial enrollment to study GI dysfunction in children with autism
March 24th, 2006
PediaMed announced that it has completed enrollment requirements for an important new phase II research study that is evaluating an investigational medication for the treatment of persistent gastrointestinal (GI) dysfunction in children with autism. In April 2005, PediaMed began accepting candidates for the clinical trial. The 22-site, phase II clinical study is designed to evaluate the efficacy of a specific treatment on improving GI symptoms. The study is also assessing whether the treatment has an impact on the unique emotional and behavioral manifestations of autism. Reaching the target number of enrolled patients is a significant milestone in this challenging...
Source: Drug Week (2006-03-24)
|
